Skip to content
thestock.space

Narayana Hrudayalaya (NH) had a P/E of 44.7× on 6 Nov 2026, below the industry P/E of 47.7×. It earns ROCE of 11% and ROE of 19%, and sales and net profit grew 20% and 9.9% a year over 3 years. Its dividend yield is 0.2%, and debt is 1.21× equity. It is a mid-cap company with a market cap of ₹38,650 Cr, ranked 6th of 40 Medical Care Facilities companies by market cap; the shares rose 4.7% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹1,902.00
Day high
₹1,925.80
Day low
₹1,885.10
Prev. close
₹1,915.50
Volume
1 L

Health check

2 good · 4 fair
  • ReturnsAhead

    +4.7% over a year, better than 5 of 7 peers.

  • Price tagIn line

    P/E 44.7 vs industry 47.7.

  • GrowthSteady

    Sales +20.5%, profit +9.9% a year over 3 years.

  • ProfitabilityAverage

    ROCE 11.4% vs peer median 11.9%.

  • Balance sheetFair

    Debt 1.21× equity, interest covered 5.0×, Piotroski 6 of 9.

  • Red flagsNone found

    No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Mid cap

₹38,650 Cr, #6 of 40 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Sep 2026: sales ₹10,273 Cr · profit ₹864 Cr
Market cap
₹38,650 Cr
Mid cap
P/E
44.7
Industry 47.7
Price to book
7.73
Peers 8.63
Dividend yield
0.24%
ROE
19.1%
Peers 11.0%
ROCE
11.4%
Peers 11.9%
Debt to equity
1.21
Debt ₹6,075 Cr
EPS (TTM)
₹42.54
Face value ₹10
OPM (TTM)
18.5%
Net margin 8.4%
Sales growth
+73.0%
Latest quarter vs a year ago
Profit growth
+16.5%
Latest quarter vs a year ago
Price to sales
3.76
EV/EBITDA 23.1

Strengths and risks

Strengths

  • Return on equity of 19.1%.
  • Quarterly sales up 73.0% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Narayana Hrudayalaya

Narayana Hrudayalaya Limited provides medical and healthcare services in India, the United Kingdom, and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, breast oncology, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult…

Headquarters
Bengaluru
Employees
11,234
Sector
Healthcare
ISIN
INE410P01011
Website
narayanahealth.org

Price range

52 weeks

₹1,589.00₹2,093.30

Today

₹1,885.10₹1,925.80
Avg volume (3M)
2.3 L
1-year return
plus 4.7%
From 52-week high
minus 9.1%

Analyst consensus

12 analysts
Strong buyMean target ₹2,265.58 plus 19.1%

Target range, with today’s price

Low ₹1,865.00High ₹2,559.00

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
KIMSKrishna Institute of Medical Sciences723.00minus 1.10%30,366138.512.878.1%11.0%19.8%21.3%−10.5%0.00%plus 2.0%
Median of 7 peers–−0.89%62,09266.18.6311.9%11.0%19.8%16.5%14.4%0.13%2.0%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
1,6442,1512,5942,6842,844
1,2411,7842,0842,2142,290
403367510470554
24.5%17.1%19.7%17.5%19.5%
22.721.327.233.649.1
42.36591.386.896.7
87.5122154156163
–−50.9−0––
295150292260343
12.6%14.8%21.9%20.4%12.3%
258127224207301
12.726.2411.0210.2014.82

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+20.5%
Profit CAGR 3Y
+9.9%
EPS CAGR 3Y
+9.9%
ROE
19.1%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
4,4914,8765,4647,858
–+8.6%+12.1%+43.8%
3,4913,6964,1566,194
1,0001,1801,3081,664
22.3%24.2%23.9%21.2%
36.743.148.137.5
69.196.9146244
210242280449
−6.2–5.5−39.7
752884936969
19.3%11.1%15.6%16.3%
606789790806
–+30.2%+0.1%+2.0%
29.8538.8638.9039.67

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
204204204204
1,9272,6793,4224,333
8841,6272,4285,857
1,1471,1141,2102,080
4,1625,6257,26512,474
2,3793,2484,1695,717
32584869.7345
6.75.8198227
6511,2371,7522,533
8012861,0763,651
4,1625,6257,26512,474

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1,0851,0679861,621
−1,174−1,458−1,325−3,700
87.74885442,340
−1.897.1205262
−522−971−1,082−875
56396−96.2746
−20.3−50.8−81.2−91

Shareholding pattern

Source: NSE filings
63.3%
promoters
  • Promoters63.27%
  • Public36.11%
  • Employee trusts0.62%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202663.27%36.11%0.00
30 Jun 202663.27%36.11%0.00
31 Mar 202663.27%36.11%0.00
31 Dec 202563.27%36.11%minus 0.58
30 Sep 202563.85%35.53%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you